Track topics on Twitter Track topics that are important to you
In the first 9 months of its 2016-2017 fiscal year, Carl Zeiss Meditec reported an 8.3% increase in revenue to 864.7 million, or 1.10 per share, compared with 798.6 million, or 0.83 per share, a year ago. Revenue in the ophthalmic devices business unit increased by 9.2% to 639.9 million compared with 585.8 million a year ago, according to a press release.
Original Article: Carl Zeiss Meditec reports 8.3% increase in 9-month revenueNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...